Nothing Found
Sorry, no posts matched your criteria
Center for Virology and Vaccine Research
3 Blackfan Circle
Boston, MA 02115 – USA
T 617.667.7000
F 617.735.4566
E CVVRcontact@bidmc.harvard.edu
CVVR Clinical Trials Unit
T 617.735.4610
E CVVRtrials@bidmc.harvard.edu
[DISPLAY_ULTIMATE_SOCIAL_ICONS]
Younger Americans Benefited Less From Booster Shots Than Older People
/in NewsAmong those under age 50, vaccination even without a booster protected strongly against hospitalization and death.. Read Article
What’s Holding Up New Omicron Vaccines?
/in NewsVaccine makers worry yet another variant will start dominating in the months it takes to roll out shots against this one. Read Article
Studies indicate J&J Covid-19 vaccine booster protects people against severe illness from Omicron variant
/in NewsTwo reports released Thursday show that people who get booster doses of Johnson & Johnson’s Janssen vaccine are well protected against severe disease and hospitalization from the Omicron variant of […]
414 days at work, zero days off: Dan Barouch and the race to develop the Johnson & Johnson vaccine
/in NewsAfter the vaccine received emergency use authorization this year, he turned to the Provincetown outbreak and Omicron. Plus, recognizing the unsung heroes of vaccine production. Read Article
‘I don’t think we’re back to square one.’ Beth Israel races to find out how much vaccines protect against Omicron
/in NewsThe hospital’s researchers are part of a global effort to understand the fast-spreading variant. Read Article
Covid Outbreak in Party Town Shows How the Pandemic Could End
/in News“Our data really puts a different perspective on the Provincetown cohort,” said Dan Barouch. Read Article
Rising Covid-19 Breakthrough Cases Hinder Efforts to Control Virus
/in News“Breakthrough infections are not rare, and they’re not unexpected, and they’re not very concerning,” said Dan Barouch. Read Article
J&J Says Covid-19 Vaccine Booster Two Months After First Shot Increases Protection
/in NewsTrial participants in the U.S. who received a second dose eight weeks after the first had 94% protection against the illness. Read Article
2nd dose of J&J COVID-19 vaccine results in stronger protection, company says
/in NewsThe shots, given two months apart, can offer 94% protection against infections. Read Article
Biden administration to begin rolling out booster shots the week of Sept. 20
/in NewsHealth care workers and nursing home residents are first in line Read Article